Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemoreflex Sensitivity in Heart Failure With Preserved Ejection Fraction

NCT06309537 is registered in ClinicalTrials.gov with Istituto Auxologico Italiano as lead sponsor.

NCT NCT06309537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06309537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemoreflex Sensitivity in Heart Failure With Preserved Ejection Fraction
Lead sponsor
Istituto Auxologico Italiano
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
December 31, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction